statlife, mammorisk, DenSeeMammo

December 20, 2016 — The U.S. Food and Drug Administration (FDA) has granted  510(k) clearance to Statlife’s DenSeeMammo, a software solution for breast density category assessment. DenSeeMammo provides a standardized and automatic breast density evaluation that mimics radiologists' visual assessment according to the BIRAD 5th Edition guidelines. The images from the mammography equipment are compared to a database of images that were previously quoted by a consensus of Mammography Quality Standards Act (MQSA) radiologists specialized in breast imaging.

 The company said the software provides a breast density assessment in agreement with a radiologist's visual assessment, but in a very reproducible way. Only the breast density visually assessed by radiologists is recommended by the BIRAD Atlas V and is clinically significant considering the masking effect and the correlation with breast cancer risk. 

The DenSeeMammo software can be combined with Statlife’s MammoRisk software for breast cancer risk assessment, it provides a breast density category assessment, a risk evaluation, and a patient report with a personalized screening program. 
 
DenSeeMammo is a software application intended for use with digital mammography systems. DenSeeMammo estimates BIRADs breast density value by analyzing digitally processed 2-D mammograms using a fully automated comparison procedure. It provides a BIRADs breast density 5th Edition category to aid radiologists in the assessment of breast density.

The software produces adjunctive information. It is not an interpretive or diagnostic aid when the final assessment of breast density category is made by an MQSA qualified interpreting physician.

DenSeeMammo is compatible with images obtained from GE Senographe Essentials systems.

For more information: www.mammorisk.com/us

Related Content

News | Artificial Intelligence

November 28, 2021 — Lunit, a medical AI provider, is returning to the 107th Radiological Society of North America (RSNA) ...

Time November 28, 2021
arrow
News | Breast Imaging

Lunit, a leading medical AI provider, announced that the U.S. Food and Drug Administration (FDA) 510(k) has cleared its ...

Time November 28, 2021
arrow
News | Breast Imaging

November 24, 2021 — Hologic Inc. will showcase its extensive portfolio of breast and skeletal health products, including ...

Time November 24, 2021
arrow
News | Flat Panel Displays

November 24, 2021 — The rise of digital imaging technology has quickly changed the way in which patient data are used ...

Time November 24, 2021
arrow
News | Mammography

November 23, 2021 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of two new ...

Time November 23, 2021
arrow
News | Women's Health

November 22, 2021 — Intrauterine contraceptive devices (IUDs) appear to have systemic effects on the body like those of ...

Time November 22, 2021
arrow
News | Breast Imaging

November 21, 2021 — Double Black Imaging expands their line of displays for digital breast imaging with the Gemini 12MP ...

Time November 21, 2021
arrow
News | Breast Imaging

November 16, 2021 — Patients with two out of the three most common types of advanced breast cancer now have an average ...

Time November 16, 2021
arrow
News | Mammography

November 15, 2021 — Volpara Health and leading mammography education provider, Mammography Educators LLC, have expanded ...

Time November 15, 2021
arrow
News | Digital Pathology

November 15, 2021 — Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and ...

Time November 15, 2021
arrow
Subscribe Now